Sandu Pharmaceuticals Ltd.
| BSE: 524703 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE751D01014 |
| BSE 00:00 | 04 Mar | 30.00 |
0 (0.00%) |
OPEN
29.55 |
HIGH
30.40 |
LOW
29.00 |
| NSE 05:30 | 01 Jan | Sandu Pharmaceuticals Ltd |
| OPEN | 29.55 |
| PREVIOUS CLOSE | 30.00 |
| VOLUME | 2965 |
| 52-Week high | 43.70 |
| 52-Week low | 10.45 |
| P/E | 23.81 |
| Mkt Cap.(Rs cr) | 21 |
| Buy Price | 30.00 |
| Buy Qty | 25.00 |
| Sell Price | 30.50 |
| Sell Qty | 100.00 |
Sandu Pharmaceuticals Ltd. (SANDUPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 860.40 | -14.10 | -1.61 | 13266.48 |
| Cipla | 811.00 | 4.80 | 0.60 | 12659.15 |
| Sun Pharma.Inds. | 613.60 | -5.05 | -0.82 | 12531.93 |
| Dr Reddy's Labs | 4502.00 | -72.30 | -1.58 | 11850.40 |
| Lupin | 1044.75 | -3.40 | -0.32 | 11025.66 |
| Apollo Hospitals | 2935.15 | -108.30 | -3.56 | 9794.50 |
| Glenmark Pharma. | 471.50 | -2.50 | -0.53 | 6712.63 |
| Alkem Lab | 2787.00 | -40.20 | -1.42 | 6677.08 |
| Cadila Health. | 447.20 | -1.80 | -0.40 | 6347.40 |
| Torrent Pharma. | 2491.30 | -6.50 | -0.26 | 6168.44 |
| Divi's Lab. | 3531.70 | -22.60 | -0.64 | 5310.57 |
| Ipca Labs. | 1913.00 | -18.15 | -0.94 | 4337.82 |
| Piramal Enterp. | 1974.95 | 18.05 | 0.92 | 4219.19 |
| Alembic Pharma | 917.00 | -5.00 | -0.54 | 4132.55 |
| Abbott India | 14806.70 | 160.70 | 1.10 | 4093.14 |
| Glaxosmi. Pharma | 1538.70 | -2.95 | -0.19 | 3224.68 |
| Jubilant Pharmo | 798.00 | 14.30 | 1.82 | 3139.90 |
| Sanofi India | 8288.50 | -38.40 | -0.46 | 3070.60 |
| Laurus Labs | 361.70 | -6.65 | -1.81 | 2797.34 |
| Gland Pharma | 2581.20 | -89.90 | -3.37 | 2633.24 |
Quick Links for Sandu Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
